Report on the Meeting of the Second ad hoc Committee on the TB Epidemic: Recommendations to Stop TB Partners
This report presents the recommendations by the 2nd ad hoc Committee on the TB epidemic.
This report presents the recommendations by the 2nd ad hoc Committee on the TB epidemic.
This report is the background document of the 2nd ad hoc Committee on the TB epidemic. The committee has reviewed progress in global TB control, examined constraints to improved TB control in high-burden countries, and sought solutions to these constraints through a wide consultative process during 2003. The results of this work are set out in this background document prepared for the meeting of the 2nd ad hoc Committee in September 2003.
This fact sheet discusses the correlation between TB and poverty. It lists the steps in fighting TB and poverty, and states that DOTS is a global strategy to fight TB and alleviate poverty and inequity.
This fact sheet explains the purpose of the Global Drug Facility (GDF) to expand access to, and availability of, high-quality TB drugs to facilitate DOTS expansion, and to enable governments and nongovernmental organizations (NGOs) to implement effective TB control programs based upon the DOTS stragegy.
This book provides government and nongovernment entities involved in TB elimination with background on the pathology of TB, its history, and the public and private response to TB in the United States.
This book is designed for medical school faculty who are interested in implementing a TB standardized patient program for medical school students.
This report presents information about the Global TB Drug Facility, a program designed to ensure access to and the availability of TB drugs.
This book is for health care workers considering embarking on TB control in prisons and covers structural, administrative, and medical issues. It is designed primarily for use in settings where there is a high incidence of TB and limited resources.
This book is for health care workers considering embarking on TB control in prisons and covers structural, administrative, and medical issues. It is designed primarily for use in settings where there is a high incidence of TB and limited resources.
These guidelines have been developed to assist national TB control programs (NTPs) in adopting specific anti-TB drug resistance surveillance systems to measure susceptibility to first-line TB drugs.